BOZEMAN, MT, February 12, 2009 /24-7PressRelease/ -- BioScience Laboratories can now test a product's efficacy when challenged with Methicillin-resistant Staphylococcus aureus (MRSA) on human skin. The recent approval from an independent institutional review board to apply MRSA US100 to human volunteers in clinical studies marks an important step forward for the infection control industry.
BioScience Laboratories' in vitro laboratory has a collection of over 200 MRSA strains. The in vitro and clinical laboratories are equipped to test not only MRSA, but many other emerging nosocomial pathogens, including Clostridium difficile spores and other drug-resistant bacteria strains that have become a growing concern for infection control professionals.
BioScience Laboratories, Inc. was founded in 1991 in Bozeman, MT, to provide antimicrobial product testing and result interpretation grounded in science. Bioscience Laboratories Inc. strives to assist its clients in strengthening their current market positions through product testing and aid in the development of new products and new markets. Today, BioScience Laboratories offers a variety of state-of-the art laboratory services and guidance regarding federal regulatory agency requirements for the healthcare, pharmaceutical, personal care and consumer products markets.
BioScience Laboratories, Inc. is an Indepentant Testing Laboratory. For further information, please contact Sabrina Bakich at 406-587-5735.